Stamford, CT -- (SBWIRE) -- 11/09/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Quantum Corp (NYSE:QTM), MannKind Corporation (NASDAQ:MNKD), Alcoa Inc (NYSE:AA), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
Quantum Corp (NYSE:QTM) ended higher +7.08% from its previous close of $1.13 and complete the day at $1.21. The total number of shares changed hands during the day was 2.65 million. After opening at $1.13, the stock hit as high as $1.21. However, it traded between $1.10 and $1.75 over the last twelve months.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained negative -23.42% during the previous three months trade. Quantum Corporation provides data protection and big data management solutions for customers ranging from small businesses to multinational enterprises. Its solutions include StorNext File System software, which provides shared access to data across various networks, operating systems, and storage platforms; StorNext Storage Manager that automatically copies and migrates data between different tiers of storage based on user-defined policies; and StorNext appliances.
For How Long QTM will Fight for Profitability? Read This Trend Analysis report
MannKind Corporation (NASDAQ:MNKD) closed yesterday at $5.13, a +9.62% increase. Around 7.15 million shares were traded, beating an-average trading volume of 5.30 million shares. The company is now valued at around $1.54 billion. The stock opened the session at $4.69 and touched its highest price point at $5.14.
MNKDS’s lowest price point for the session stood at $4.69 and its 52 week price range stood at $1.88 - $8.70. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia.
For How Long MNKD’s Gloss will Attract Investors? Find out via this report
Alcoa Inc (NYSE:AA) moved +1.23 percent higher at $9.06 and traded between $8.78 and $9.08 after opening the day at $9.03. Its performance over the last five days remained -2.27%, which stands at 14.11% for a month. Going back further than one month, 1-year performance after recent close was 4.38%.
The company has a total of 1.07 billion outstanding shares and its total market capitalization is $9.69 billion. Its beta value stands at 1.92 times and earnings per share was $0.25. Alcoa Inc. engages in the production and management of primary aluminum, fabricated aluminum, and alumina. The company operates in four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions. The Alumina segment engages in mining of bauxite, which is then refined into alumina. The Primary Metals segment produces aluminum.
For How Long AA’s Gloss will Attract Investors? Find out via this report
Merrimack Pharmaceuticals Inc (NASDAQ:MACK)’s shares dropped, -3.33 percent from its previous close of $2.555 to close at $2.47. The stock is up around -59.44% this year and -61.52% for the last 12 months. Around 2.52 million shares changed hands yesterday, higher from an-average trading volume of 1.72 million shares. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States. The company uses its Network Biology proprietary systems biology-based approach to biomedical research.
Will MACK Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)